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Genomic imprintingSeveral imprinted genes have been implicated in the regulation of placental function and embryonic growth.
On distal mouse chromosome 7, two clusters of imprinted genes, each regulated by its own imprinting center
(IC), are separated by a poorly characterized region of 280 kb (the IC1–IC2 interval). We previously generated
a mouse line in which this IC1–IC2 interval has been deleted (Del7AI allele) and found that maternal
inheritance of this allele results in low birth weights in newborns. Here we report that Del7AI causes a partial
loss of Ascl2, a maternally expressed gene in the IC2 cluster, which when knocked out leads to embryonic
lethality at midgestation due to a lack of spongiotrophoblast formation. The hypomorphic Ascl2 allele causes
embryonic growth restriction and an associated placental phenotype characterized by a reduction in placental
weight, reduced spongiotrophoblast population, absence of glycogen cells, and an expanded trophoblast giant
cell layer. We also uncovered severe defects in the labyrinth layer of maternal mutants including increased
production of the trilaminar labyrinth trophoblast cell types and a disorganized labyrinthine vasculature. Our
results have important implications for our understanding of the role played by the spongiotrophoblast layer
during placentation and show that regulation of the dosage of the imprinted gene Ascl2 can affect all three
layers of the chorio-allantoic placenta.enetics, Life Sciences Centre,
ces Mall, University of British
. Fax: +1 604 822 5348.
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
In regions of the mammalian genome subject to genomic
imprinting, genes tend to be epigenetically regulated in clusters,
suggesting that long-range mechanisms coordinate monoallelic
expression during development (Jones and Lefebvre, 2009; Reik and
Walter, 2001). Distal mouse chromosome 7 (Chr 7), which shares
homology with the Beckwith–Wiedemann Syndrome (BWS) region
on human chromosome 11p15.5, is approximately 1 Mb in size and
contains two imprinted clusters, each regulated by its own cis-acting
differentially methylated region (DMR), commonly referred to as
imprinting center 1 and imprinting center 2 (IC1 and IC2).
The distal end of the IC1 subdomain and the proximal end of the
IC2 subdomain are separated by a distance of about 300 kb. IC1 has
been shown to control the maternally expressed H19 gene and
paternally expressed Igf2 gene via an epigenetically controlled CTCF-
binding insulator element (Bell and Felsenfeld, 2000; Hark et al.,
2000). Themechanism of IC2-mediated epigenetic silencing of several
genes both centromeric and distal to its position over a relatively
broad area (over 800 kb) is not as clear as is the case for IC1 and likely
involves multiple components. Speciﬁcally, in the IC2 cluster of genes,at least eight protein-coding genes (Ascl2, Tssc4, Cd81, Kcnq1, Cdkn1c,
Slc22a18, Phlda2, and Osbpl5) are known to be paternally silenced by
the production and elongation of the large ncRNA Kcnq1ot1,
transcribed from the unmethylated paternal IC2 (Fitzpatrick et al.,
2002; Mancini-Dinardo et al., 2006; Shin et al., 2008). The current
paradigm of imprinted regulation in this region proposes that
Kcnq1ot1 transcription or the ncRNA itself is responsible for initiating
and recruiting repressive H3K9me2, H3K9me3, and H3K27me3marks
speciﬁcally in the placenta to the paternal allele along the IC2 domain
(Lewis et al., 2004; Pandey et al., 2008; Umlauf et al., 2004; Wagschal
et al., 2008).
Even less is known about the large region between the IC1 and IC2
subdomains and information on this intervening region has only
recently become available (Lefebvre et al., 2009; Shirohzu et al.,
2004). It has been problematic to study because the entire region is
repeat-rich and consists mostly of retroelements and tandem repeats,
with one known gene, Tyrosine hydroxylase (Th) (Shirohzu et al.,
2004). Th-null mice die in utero but can be rescued by supplementing
pregnant females with L-DOPA, the next metabolite in catecholamine
biosynthesis pathway (Zhou et al., 1995). To study whether the IC1–
IC2 interval plays a role in regulating imprinting in this region, we
previously generated a ~280 kb deletion of the IC1–IC2 interval called
the Del7AI allele, with breakpoints 5′ of Ins2 in the IC1 sub-domain and
3′ of Ascl2 at the proximal end of the IC2 sub-domain (Lefebvre et al.,
2009). We reported that the Del7AI deletion was viable upon both
paternal andmaternal inheritance, where it is recovered inMendelian
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(Lefebvre et al., 2009). Homozygous Del7AI/Del7AI mice died in utero
due to a lack of Th, consistent with the observed Th-null phenotype.
This was demonstrated by showing that homozygous deletion
mutants can be rescued to term by supplementing pregnant Del7AI
heterozygous females with L-DOPA during gestation (Lefebvre et al.,
2009; Zhou et al., 1995). Otherwise, our analysis of the Del7AI allele
indicated that the deletion does not perturb acquisition or mainte-
nance of imprinting marks at the ﬂanking imprinting centers,
regardless of parental inheritance (Lefebvre et al., 2009).
Several genes in the distal Chr 7 imprinted domain have been
implicated in placental development and the regulation of embryonic
growth. These include Igf2 (Baker et al., 1993), Ascl2 (Guillemot et al.,
1995), Cdkn1c (Andrews et al., 2007; Takahashi et al., 2000), and
Phlda2 (Frank et al., 2002; Salas et al., 2004; Tunster et al., 2010). The
achaete-scute complex homolog 2 gene Ascl2 codes for a basic helix–
loop–helix (bHLH) transcription factor implicated in lineage speciﬁ-
cation in extra-embryonic tissues (Guillemot et al., 1994) as well as in
the adult intestinal epithelium (van der Flier et al., 2009). Although
Ascl2 expression in extra-embryonic tissue is imprinted with
exclusive transcription from the maternal allele (Guillemot et al.,
1995), it is biallelically expressed in adult LGR5-positive stem cells
(van der Flier et al., 2009). During development, Ascl2 is ﬁrst detected
during preimplantation stages, with predominant expression in the
trophectoderm cells of the blastocyst (Rossant et al., 1998). Following
implantation, Ascl2 transcripts are abundant in diploid cells of the
ectoplacental cone and chorion (Guillemot et al., 1994; Rossant et al.,
1998). In the chorio-allantoic placenta, Ascl2 expression becomes
restricted to spongiotrophoblast cells, with some patchy expression
also detected in the labyrinth layer (Rossant et al., 1998). The role of
Ascl2 in the development of the extra-embryonic lineages was
previously addressed by generating a null allele of Ascl2 by gene
targeting (Guillemot et al., 1994). Ascl2-null conceptuses die of
placental failure at E10.0 (Guillemot et al., 1994; Tanaka et al., 1999).
Mutant placentae show an absence of the spongiotrophoblast layer, as
shown by loss of Tpbpa- and Flt1-positive cells as early as E7.5, as well
as an expansion of the trophoblast giant cell layer (Guillemot et al.,
1994; Oh et al., 2008).
Here we show that the Del7AI allele, which is associated with low
birth weights in maternal heterozygotes, acts as a hypomorphic
Ascl2 allele. Since the mutant embryos are viable, although growth
retarded, we were able to assess the phenotypic consequences of
reduced Ascl2 levels on placental development. Our results show that
Ascl2 function is dosage-sensitive and that hypomorphs exhibit
developmental abnormalities in the three main layers of the mature
placenta.Material and methods
Mice and genotyping
Generation and genotyping of the Del7AI allele were previously
described (Lefebvre et al., 2009). The Del7AI allele (Del(7Ascl2-Ins2)1Lef;
MGI:3662901) is a ~280 kb deletion of the interval between Ins2 and
Ascl2 (from NCBI m37 coordinates 149,868,122 to 150,148,458)
obtained by Cre-loxP recombination in germ cells (Lefebvre et al.,
2009). The Ascl2-lacZ allele (Ascl2tm1.1Nagy; MGI:2155757) has been
described previously (Tanaka et al., 1999). Although the Ascl2 open-
reading frame is undisturbed in this allele, the introduction of an IRES-
lacZ-pA cassette in the 3′UTR interferes with production of ASCL2,
such that Ascl2-lacZ behaves as a null allele (Tanaka et al., 1999). Note
that for heterozygous genotypes, the maternal allele is always given
ﬁrst. All animals in this study were maintained on the outbred CD-1
mouse background. All animal experiments were performed under
certiﬁcate A07-0160 from the UBC Animal Care Committee andcomplied with the Canadian Council on Animal Care guidelines on the
ethical care and use of experimental animals.
In situ hybridization (ISH)
E9.5, E13.5, and E15.5 placentae were dissected in PBS and ﬁxed in
fresh 4% paraformaldehyde/1×PBS (RNase free) overnight at 4 °C. For
E9.5 placentae, entire conceptuses were ﬁxed to ensure integrity of
cryostat sections during the ISH procedure. Antisense and sense
strand probes for Ascl2, Tpbpa (4311), Pcdh12, Gcm1 and Cdkn1cwere
DIG-labeled and used for ISH on 10 μm cryostat sections for E13.5 and
E15.5 placentae and 12 μm sections for E9.5 placentae as previously
described (Oh-McGinnis et al., 2010). Nuclear fast red was used as a
counterstain.
Immunohistochemistry
E7.5 conceptuses as well as E13.5 and E15.5 placentae were
dissected in cold PBS and ﬁxed in fresh 4% paraformaldehyde
overnight at 4 °C, parafﬁn-embedded, sectioned (12 μm) and sub-
jected to immunohistochemistry as previously described, using the
Vectastain Elite ABC kit and DAB substrate (Vector Labs) (Oh-
McGinnis et al., 2010). To detect the PHLDA2 protein in the labyrinth
layer, a 1:1000 dilution of the anti-PHLDA2 polyclonal antibody was
used (Frank et al., 1999). ASCL2 IHCwas performed with the Millipore
clone 8F1 monoclonal antibody (Cat. # MAB4417) at a 1:50 dilution
(van der Flier et al., 2009). To identify fetal capillaries of the labyrinth
layer (Harbers et al., 1996), a 1:25 dilution of rabbit polyclonal anti-
laminin antibody (Sigma L9393) was used. Hematoxylinwas used as a
counterstain.
Periodic acid Schiff stain
E15.5 parafﬁn sections were deparafﬁnized, treated with 1%
periodic acid for 5 min, washed in tap water, followed in distilled
water. The sections were then covered in Schiff's solution for about
15 min and rinsed in running tap water for about 15 min. Hematox-
ylin was used as a counterstain and Scott's Tap water substitute was
used to help sharpen the contrast. Sections were then dehydrated and
mounted with Entellan mounting medium (EM Science) and cover-
slipped with glass.
DAPI stain
E15.5 parafﬁn sections were deparafﬁnized and treated with 4′,6-
diamidino-2-phenylindole (DAPI) (1:5000 in PBS) for 5 min. Sections
were then washed with distilled water, mounted with Vectashield
(Vector Labs) and coverslipped with glass.
Expression analysis by quantitative real-time RT-PCR (qRT-PCR)
For total expression level analysis of IC1- and IC2-regulated genes,
random-primed cDNA was generated from E9.5 or E15.5 placentae as
previously described and cDNAwas subject to qRT-PCR (Oh-McGinnis
et al., 2010). qRT-PCRs were performed on three to four individual
Del7AI/+ placentae, three+/Del7AI placentae and three to six wild type
placentae with three technical replicates per individual placentae. All
primer sequences for qRT-PCR analyses are available in Supplemen-
tary Table 1.
Placental fetal vasculature casts
Fetal vascular corrosion casts of E14.5 placentaewere generated by
following the procedure previously described (Whiteley et al., 2006).
Vascular casts were analyzed by scanning electron microscopy at the
UBC Bioimaging Facility.
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Reduced placental and embryonic weights in maternal Del7AI/+
heterozygotes
We previously reported that the Del7AI allele is associated with a
new imprinted phenotype characterized by a growth restriction of
approximately 20% at birth and seen only in maternal Del7AI/+
heterozygous pups (Lefebvre et al., 2009). To assess whether this
postnatal phenotype reﬂects an in utero growth restriction, we
measured placental and embryonic weights at E15.5 from reciprocal
crosses between wild type (CD-1 outbred strain) and Del7AI
heterozygous mice. Consistent with the absence of a growth
phenotype at birth, no difference was found between the embryonic
or placental weights of the paternal +/Del7AI heterozygotes and their
wild type littermates (Fig. 1A). However upon maternal transmission
of the deletion, we observed a signiﬁcant (~28%) reduction inDel7AI/+
placental weights at E15.5 compared to their wild type littermates
(Fig. 1B). Weights of Del7AI/+ embryos were concurrently smaller
than wild type littermates at this stage but to a lesser degree (~7%).
Our results show that maternal inheritance of Del7AI is associated with
growth defects during development and suggest that embryonic
growth restriction occurs later than E15.5 as a consequence of a
primary placental phenotype, as described previously for other
imprinted mouse models of intrauterine growth restriction such as
the Esx1 knock-out (Li and Behringer, 1998) and the placental-speciﬁc
loss of Igf2 (Constância et al., 2002).Fig. 1. Reduced placental and embryonic weights in maternal Del7AI heterozygotes at E15.5.
type and Del7AI heterozygous conceptuses obtained from reciprocal crosses. Bars show the av
are shown following paternal (A) and maternal (B) transmission of the Del7AI deletion. Diff
Student t test (p values). Asterisks mark mutant results signiﬁcantly different from those oBoth Ascl2 and Phlda2 are perturbed in maternal Del7AI/+ placentae
The imprinted phenotype associated with Del7AI suggests that the
deletion interferes with the expression of a maternally expressed
placental growth regulator during development. Of the currently
annotated protein-coding genes deleted in the Del7AI allele (Ins2
Ensembl isoform Ins-006, Gm6471, and Th) only Th is known to be
expressed in the placenta, where it has been reported to be
preferentially expressed from the maternal allele (Schulz et al.,
2006). However, whereas the embryonic lethality of Del7AI/Del7AI
homozygotes can be pharmacologically rescued by provision of
exogenous L-DOPA during pregnancy (the product of the reaction
catalyzed by TH), such treatment has no effect on the growth
restriction phenotype of Del7AI/+ heterozygotes (Lefebvre et al.,
2009). These observations suggest that the deletion might interfere
with the expression of ﬂanking imprinted genes, several of which
have been implicated in placental biology such as Igf2 in the proximal
IC1 subdomain(Baker et al., 1993), and Ascl2 (Guillemot et al., 1994),
Cdkn1c (Zhang et al., 1998), and Phlda2 (Frank et al., 2002) in the
distal IC2 sub-domain. To address this possibility, we analyzed by
quantitative reverse transcriptase PCR (qRT-PCR) the expression
levels in E9.5 placentae of imprinted genes located proximally (IC1
subdomain) or distally (IC2 subdomain) to the breakpoints of the
Del7AI deletion (Figs. 2A–B). In Del7AI/+ placentae, the gene immedi-
ately distal of the deletion breakpoint, Ascl2, was signiﬁcantly lower in
the maternal Del7AI/+ placentae compared to wild type littermates,
with an overall reduction in expression levels of approximately two-Scatterplots of individual placental and embryonic weights at E15.5 for cohorts of wild
erage weight±standard deviation for the given numbers of measurements (n). Results
erences in wild type and mutant means were evaluated using the two-tailed unpaired
f their wild type littermates (pb0.05).
Fig. 2. Total expression levels of IC1- and IC2-regulated imprintedgenes in reciprocal heterozygousDel7AIplacentae atE9.5. (A) Schematic representation ofmouse chromosome7 showing
the breakpoints of theDel7AI allele relative to IC1 and IC2.DNAmethylation status at the imprinting centers is shownby lollipops (white, unmethylated; black,methylated) on thematernal
(M, black) and paternal (P, gray) homologues. (B)Map of the IC1 and IC2 clusters showing selectivematernally (black) andpaternally (gray) expressed genes. (C) qRT-PCRwas performed
on E9.5 placentae for the following genes: H19, Igf2, Ascl2, Tssc4, Cdkn1c, Phlda2 and Osbpl5. qRT-PCR was carried out as technical triplicates on three individual placentae (biological
replicates) for each genotype and the error bars show the standard deviation for biological triplicates. Expression is relative to the reference housekeeping gene, Peptidylprolyl isomerase A
(Ppia). Asterisks indicate mutant values signiﬁcantly different from wild type values, using two-tailed unpaired Student t test (Ascl2, p=0.006; Phlda2 p=0.005).
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maternal Del7AI/+ placentae compared to wild type littermates, also
by approximately two-fold (Fig. 2C). The same expression changes at
Ascl2 and Phlda2were also observed in E15.5 placentae (Fig. S1A). The
rest of the genes analyzed in the IC2 or IC1 clusters, including Igf2,
were unaffected in maternal Del7AI/+ placentae. Unlike what is
observed for conceptuses inheriting the deletion maternally, we
found no signiﬁcant difference between +/Del7AI placentae and wild
type littermates for the IC1 and IC2 subdomain genes analyzed at this
stage (Fig. 2C).
To conﬁrm the status of Ascl2 and Phlda2 expression in maternal
Del7AI/+ placentae using an independent method, we carried out in
situ hybridization (ISH) and immunohistochemistry (IHC) on E9.5 and
E13.5 Del7AI placentae, respectively. At E9.5, Ascl2 expression is
highest in the spongiotrophoblast layer of the developing placenta,
with weak expression also detected in the labyrinthine layer (Rossant
et al., 1998). We found a general decrease in Ascl2 levels within these
placental layers in Del7AI/+ placentae. (Fig. 3A). To ask whether the
difference in Ascl2 expression was due to a general decrease in the
number of spongiotrophoblast cells where Ascl2 is predominantly
expressed, we performed ISH for Tpbpa (4311), a marker of the
spongiotrophoblast layer at E9.5 (Lescisin et al., 1988). We found nodecrease in the number of Tpbpa-positive cells in mutant placentae at
this early stage (Fig. 3B). We noted that Tpbpa levels appeared higher
in some (but not all) mutant sections analyzed, but this expression
difference was not found to be statistically signiﬁcant by qRT-PCR
analysis (Fig. S1C). As a control, we also performed ISH on another
imprinted gene in the IC2 cluster, Cdkn1c, which is critical to
placentation and expressed throughout the placenta at this stage,
and did not observe any changes in levels or expression patterns
(Fig. 3C), consistent with our qRT-PCR results.
Although Phlda2 (also known as Ipl) is broadly expressed in the
ectoplacental cone and chorion at E8.0 (Dunwoodie and Beddington,
2002), it eventually becomes restricted to trophoblast cells of the
labyrinthine layer such that by E10.5 it is predominantly expressed in
syncytiotrophoblast layer I (SynT-I) with some lower levels in layer II
(SynT-II) (Frank et al., 1999, 2002; Simmons et al., 2008a). At E13.5,
we observed an overall increase in PHLDA2 protein expression by IHC
in Del7AI/+ heterozygotes with a broader distribution of Phlda2-
expressing foci throughout the labyrinth (Fig. 3D). Our results show
that Del7AI does not have a trans effect on the levels of Igf2 transcribed
from the wild type paternal homologue, but rather affects the
maternally expressed genes Ascl2 and Phlda2 of the IC2 sub-domain
in cis.
Fig. 3. Abnormal expression of the maternally expressed genes Ascl2 and Phlda2 in Del7AI/+ placentae. The expression patterns of Ascl2 (A), Tpbpa (B) and Cdkn1c (C) were analyzed
by ISH on frozen sections of wild type (+/+) andmaternal deletion (Del7AI/+) placentae collected at E9.5. Multiple sections from two placentae of each genotype were assessed and
representative sections are shown. Sense probes are not shown. The blue stain shows gene expression. Nuclear fast red was used as the counterstain. (D) PHLDA2 IHC at E13.5. The
brown stain shows protein expression in the labyrinth. Scale bar: 0.5 mm. sp: spongiotrophoblast layer, lab: labyrinthine layer, d: decidua.
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Ascl2-null conceptuses
In light of our results showingmisregulation of bothAscl2 and Phlda2
when the deletion is maternally inherited, we sought to distinguish
between two possible mechanisms consistent with our observations. In
the ﬁrst model, the deletion could have direct although opposite effects
on the expression levels of Ascl2 and Phlda2. According to the second
model, Del7AI has a direct effect on Ascl2 levels, reducing them by 50%,
and one of the consequences of this hypomorphic Ascl2 allele is an
increase in Phlda2 levels in the labyrinth.
Unlike Ascl2 expression which is restricted to the extra-embryonic
tissues, Phlda2 is expressed in the developing embryo and was
isolated as a mesoderm-enriched cDNA clone from gastrulation stage
embryos (Dunwoodie and Beddington, 2002). To determine whether
the deletion also affects this embryonic expression of Phlda2, we
carried out a Phlda2 qRT-PCR analysis on E13.5 Del7AI/+ embryos. We
found no difference in Phlda2 expression levels between Del7AI/+ and
wild type embryos (Fig. 4A), suggesting that the Del7AI allele has no
impact on embryonic Phlda2 levels.
A prediction from the second model is that one would expect to
observe an upregulation of Phlda2 in placentae deﬁcient for Ascl2,
before the manifestation of the lethality observed at E10.0 (Guillemot
et al., 1994). To address this, we took advantage of an Ascl2-lacZ
knock-in mouse line (Ascl2-lacZ allele, Ascl2tm1.1Nagy; MGI: 2155757).
Maternal inheritance of the Ascl2-lacZ allele (Ascl2lacZ/+ heterozy-
gotes) results in midgestational lethality due to a lack of spongio-
trophoblast formation (Tanaka et al., 1999), a phenotype similar to
the one described for the original knock-out allele (Guillemot et al.,
1994). Although it was unclear why the insertion of an IRES-lacZ
reporter cassette in the 3′UTR of Ascl2 should generate a null allele
(Tanaka et al., 1999), we found that Ascl2mRNA levels are very low in
Ascl2lacZ/+ placentae at E9.5 (Fig. 4B). We performed qRT-PCR for
Phlda2 on these mutant placentae and found a slight but signiﬁcant
increase (15%) in Phlda2 expression in the mutant placentae
compared to wild type littermates (Fig. 4B), establishing that loss of
Ascl2 by itself can lead to altered Phlda2 levels in the placenta.
We next investigatedwhether this increase in Phlda2 expression in
Ascl2-deﬁcient placentae was paralleled by a general increase in
syncytiotrophoblast markers at E9.5.We performed qRT-PCR for three
syncytiotrophoblast markers: syncytin-A (Syna), a marker of syncy-
tiotrophoblast layer I (Simmons et al., 2008a) required for syncytio-trophoblast formation by cell fusion (Dupressoir et al., 2009); Glial
cells missing homolog 1 (Gcm1), a marker of syncytiotrophoblast layer
II of the labyrinth (Anson-Cartwright et al., 2000; Simmons et al.,
2008a), and required for branching morphogenesis in the labyrinth
following chorio-allantoic fusion (Anson-Cartwright et al., 2000); and
Distal-less homeobox 3 (Dlx3), a pan-speciﬁc labyrinth trophoblast
marker (Simmons et al., 2008a), required for normal morphogenesis
of the labyrinthine layer(Morasso et al., 1999). Although we observed
a general decrease in these three markers in Ascl2-null placentae at
E9.5, signiﬁcant differences with wild type littermates were only
detected for the syncytiotrophoblast layer I gene Syna (Fig. 4C), a
marker of the cell population where Phlda2 is predominantly
expressed (Frank et al., 2002). Note that although the increase in
Phlda2 levels at E9.5 is less pronounced in Ascl2-null (Fig. 4B) then in
hypomorphic Del7AI/+ placentae (Fig. 2C), the concomitant decrease in
Syna seen in Ascl2-null placentae (Fig. 4B) is not observed in Del7AI/+
samples (Fig. S1B), suggesting a decrease in Phlda2-expressing cells in
the null placentae.
Taken together, our analyses of Del7AI/+ embryos and Ascl2-null
placentae suggest that Ascl2 operates upstream of Phlda2 in the
placenta and that Del7AI acts primarily as an Ascl2 hypomorphic allele.
Unlike what has been described for the phenotypes of the Ascl2 KO
(Guillemot et al., 1994) and Ascl2-lacZ (Tanaka et al., 1999) alleles,
maternal inheritance of Del7AI does not cause an embryonic lethality
phenotype and therefore offered us the opportunity to study the
consequences of reduced Ascl2 levels on the morphogenesis of the
mature placenta.
Increased trophoblast giant cell numbers in Del7AI/+ heterozygotes
One of the phenotypic consequences of loss of Ascl2 is an increase
in the number of parietal trophoblast giant cells making up the giant
cell layer of the mutant placentae before manifestation of the lethality
at E10.0 (Guillemot et al., 1994). We found that reduced levels of Ascl2
in maternal Del7AI heterozygotes are also accompanied by a thicker
giant cell layer, readily seen in hematoxylin and eosin (H&E) stained
sections (Fig. 5A). At higher magniﬁcation, we observed a drastic
thickening of the layer, which is usually a single cell layer in wild type
placentae, but appears as a thick stack of 4 to 6 giant cells in the
mutant placentae at E15.5 (Fig. 5B). DAPI staining conﬁrmed that
these cells have large polyploid nuclei, a characteristic of endoredu-
plicating giant cells (Fig. 5C).
Fig. 4. Dysregulation of Phlda2 in Ascl2-null placentae. (A) Phlda2 qRT-PCR on E13.5 embryo was carried out on three technical replicates each from three individual Del7AI/+
embryos and three wild type littermate individual embryos (biological replicates) and the error bars shown are the standard deviation for biological replicates. Expression is relative
to Ppia. No signiﬁcant difference was found between the two genotypes (p=0.8). Gene expression analysis by qRT-PCR on total E9.5 placental RNA from Ascl2lacZ/+ (Ascl2−/+)
mutants andwild type littermates (Ascl2+/+). Analysis is presented for (B) Ascl2 and Phlda2, as well as the labyrinth trophoblast markers Syna, Gcm1, andDlx3 (C). The results show a
signiﬁcant increase in Phlda2 expression in Ascl2-deﬁcient placentae but not for the syncytiotrophoblast markers Gcm-1 and Dlx3. Synawas also downregulated in mutant placentae.
Expression levels are relative to Ppia levels. Asterisks mark mutant levels statistically different from wild type levels (for Ascl2 p=0.0008; for Phlda2 p=0.002, and p=0.012 for
Syna).
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glycogen cells in mutant placentae
The main reported phenotype caused by Ascl2 deﬁciency is the
absence of a spongiotrophoblast layer (also known as junctional zone)
(Guillemot et al., 1994). Although at the stage of the lethality this layer
is mostly composed of spongiotrophoblast cells, past mid-gestation a
second cell population, the trophoblast glycogen cells starts to
populate this layer and eventually migrate into the decidua (Coan
et al., 2006). We found that both of these cell types were severely
affected in Del7AI/+ placentae.
In histological sections, the labyrinth appears directly juxtaposed
to the expanded giant cell layer in the mutants, with no evidence of
spongiotrophoblast or glycogen cells at E15.5, within the spongio-
trophoblast layer or above the giant cell layer (Fig. 5B). The
trophoblast gene Tpbpa is an early marker of spongiotrophoblast
cells (Lescisin et al., 1988) but is eventually also expressed in
trophoblast glycogen cells starting at E11.5 (Teesalu et al., 1998).
We analyzed the expression of Tpbpa by in situ hybridization (ISH) on
frozen sections of wild type and Del7AI/+ placentae at E15.5. In the
wild type placenta, Tpbpa is strongly expressed in a broad population
of spongiotrophoblast cells overlying the labyrinth as well as in
trophoblast glycogen cells within the spongiotrophoblast layer and
within the decidua (Fig. 6A). In the mutant placentae, only a thin layer
of Tpbpa-expressing spongiotrophoblast cells is detected, with no sign
of glycogen cells. This conspicuous absence of glycogen cells was also
conﬁrmed by periodic acid Schiff (PAS) staining (Fig. 6D), which
detects glycogen producing cells (Adamson et al., 2002), as well as by
ISH for two other markers of trophoblast glycogen cells, Pcdh12
(Rampon et al., 2005) (Fig. 6B) and Cdkn1c (Georgiades et al., 2002)
(Fig. 6C). Cdkn1c is expressed at low levels in the labyrinth in both
Del7AI/+ and wild type placentae, but is most highly expressed inglycogen cells in the maternal decidua, where signal is detected in
wild type but not in Del7AI/+ placentae (Fig. 6C). We investigated the
spongiotrophoblast to labyrinth ratio and we found that although the
labyrinth area of Del7AI/+ placentae is similar to wild type, the
spongiotrophoblast is reduced by about six-fold in the mutants.
Our results show that the correct dosage of Ascl2 levels is critical
for proper development of the spongiotrophoblast layer and suggest
that most of the weight loss observed in mutant placentae is
attributable to a total absence of glycogen cells and a drastic decrease
in the spongiotrophoblast cell population.
Dysmorphogenesis of the labyrinth layer in mutant placentae
Although Ascl2 is not expressed in the labyrinth layer of themature
placenta, we have shown that the absence or decreased levels of Ascl2
lead to an upregulation of Phlda2, which is expressed at high levels in
syncytiotrophoblast layer I (SynT-I) of the trilaminar labyrinthine
trophoblast from E10.5 to E12.5, after which stage a sharp decrease in
PHLDA2-positive cells is observed (Frank et al., 2002). To assess
whether other trophoblast cell types of the labyrinth were also
affected in Del7AI/+ placentae at E15.5, we analyzed the expression of
Placental lactogen-II (Prl3b1/Pl-II) and Gcm1 by ISH. At this stage,
Prl3b1 is expressed in three different trophoblast populations: parietal
trophoblast giant cells (the polyploid cells of the giant cell layer),
spongiotrophoblast, as well as the mononucleated giant cells lining
the maternal blood sinusoids in the labyrinth (sinusoidal trophoblast
giant cells) (Simmons et al., 2008b). In the mutant placentae,
expression of Prl3b1 is mostly seen in the thickened giant cell layer
in the basal region, but also reveals a marked increased in the density
of sinusoidal giant cells within the labyrinth (Fig. 7A). A similar result
was obtained for Gcm1 (Fig. 7B), a marker of the labyrinth
syncytiotrophoblast layer II (Simmons et al., 2008a). In light of the
Fig. 5. Thickening of the giant cell layer in maternal Del7AI heterozygotes. Overall
morphology of wild type and Del7AI/+ placentae at E15.5 as revealed by hematoxylin
and eosin (H&E) staining (A–B) and DAPI staining (C). Whereas the giant cell layer is
hard to detect at lower magniﬁcation in wild type placentae (A), a thick layer is clearly
visible in the mutants (arrowheads). At higher magniﬁcation, the single cell layer seen
in wild type placentae (dotted line) is replaced by a 4 to 6 cell layer in the mutants (B).
Also noticeable is the absence of clear spongiotrophoblast and trophoblast glycogen
cells in proximity of the giant cell layer in the mutants. (C) DAPI staining readily
identiﬁes the giant polyploid nuclei of the cells stacked at the giant cell layer in the
mutants. Scale bar: 500 μm (A); 100 μm (B–C). d: decidua; TGC: parietal trophoblast
giant cells; SpT: spongiotrophoblast; GlyT: trophoblast glycogen cells; lab: labyrinth
layer.
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trophoblast layers and the fetal vasculature, we also analyzed the
architecture of fetal blood vessels in mutant placentae by immuno-
staining for laminin, a marker of the basement membrane associatedFig. 6. Abnormal spongiotrophoblast and glygocen cell phenotype inmaternal Del7AI heterozy
Multiple sections from two placentae of each genotype were assessed and representative
(D) Periodic acid Schiff (PAS) stain revealing glycogen cells. Dark pink/purplish stain shows
SpT: spongiotrophoblast; GlyT: trophoblast glycogen cells; lab: labyrinth layer.with fetal endothelial cells. Our results again highlight important
defects in the structure of the labyrinth, characterized by a denser
network of fetal blood vessels in the mutant labyrinth (Fig. 7C). Note
that despite these abnormalities in labyrinthine structures, the
mutant placentae do not show evidence for increased thickness
between the fetal and maternal circulations (Fig. S3).
To investigate further the defects in labyrinthine vasculature
suggested by the differences in laminin stain as well as labyrinth
trophoblast cell types, we performed fetal vasculature corrosion cast
experiments (Adamson et al., 2002; Whiteley et al., 2006). Both a
lateral view and maternal view of the Del7AI/+ labyrinth revealed a
greater degree of disorganization compared to wild type (Figs. 7D–E).
In the wild type placenta, the labyrinth is subdivided into functional
units of capillary beds arranged in separate villous branches, each
served by one arteriole and one venule. In the maternal Del7AI/+
heterozygotes, however, these subdivisions of the capillary branching
were not clear and individual functional units could not be dissected
from themutant resin casts (Fig. 7D). Observation of thematernal side
of the fetal vasculature reveals this phenotype in an even more
dramatic way (Fig. 7E). In the wild type placenta, the discrete
functional unit of capillaries are clearly demarcated and separated by
spaces ﬁlled by ﬁnger-like projections of the spongiotrophoblast as
well as maternal blood space. In the mutants, this organization is lost
and fetal blood vessels ﬁll the entire diameter of the placenta. Our
results suggest that sub-optimum levels of Ascl2 not only affect
the spongiotropoblast and trophoblast glycogen cells, but also lead
to expansion of trophoblast cell types in the giant cell layer and
labyrinth.Discussion
We previously reported that maternal inheritance of a deletion of
the ~280 kb intergenic region between the two imprinted domains on
distal Chr 7 is associated with reduced birth weights (Lefebvre et al.,
2009). Here we show that upon maternal inheritance of Del7AI, the
expression levels of the genes in the IC1 and IC2 subdomains are
unaffectedwith the exception of a decrease in Ascl2 expression. This is
accompanied by a reduction in placental weight and a severe
placental phenotype characterized by a reduced spongiotrophoblast,
absence of trophoblast glycogen cells, expanded giant cell layer and
a disorganized labyrinth. We also observed an increase in Phlda2gotes at E15.5. (A) Tpbpa, (B) Pcdh12, and (C) Cdkn1c ISH performed on E15.5 placentae.
sections are shown. Sense probes not shown. The blue stain shows gene expression.
glycogen staining. Scale bar: 0.5 mm. d: decidua; TGC: parietal trophoblast giant cells;
Fig. 7. Dysmorphogenesis of the labyrinth layer in Del7AI/+ placentae. ISH for (A) Prl3b1 and (B) Gcm1 on frozen sections of wild type and mutant placentae at E15.5. Multiple
sections from two placentae of each genotype were assessed and representative sections are shown. Sense probes are not shown. The blue stain shows gene expression. Prl3b1 is
expressed in parietal trophoblast giant cells, spongiotrophoblast and mononucleated sinusoidal trophoblast giant cells of the labyrinth. In the mutants, the spongiotrophoblast
staining is replaced by a thicker giant cell layer, and the labyrinth signal is denser. Gcm1 is a marker of the syncytiotrophoblast II of the labyrinth. As seen for Phlda2 (expressed in
syncytiotrophoblast I) and Prl3b1, we observed a denser network of Gcm1-expressing cells in the mutant placenta. (C) IHC for laminin marks the basement membrane of the fetal
blood vessels and revealed a denser network of capillaries in themutant labyrinth. The brown stain shows protein expression. (D–E) Feto-placental vasculature of thematernal Del7AI
heterozygotes. Representative scanning electron micrographs of E14.5 fetal vascular corrosion casts. (D) Lateral view; (E) top view from maternal side. Four fetal vasculature casts
were assessed per genotype. Scale bar: 1 mm.
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effect of decreased Ascl2 expression (see below).
We have previously demonstrated that inheritance of Del7AI does
not affect the transcription of the ncRNA Kcnq1ot1 (Lefebvre et al.,
2009). The analysis of IC2-regulated genes presented here also argues
against a global effect of the deletion on the entire cluster of imprinted
genes. The mechanism whereby Ascl2 is decreased in Del7AI/+
heterozygotes is currently under investigation. One possibility is
that the Del7AI allele deletes a placental-speciﬁc enhancer of Ascl2
expression on the maternal allele. However, to date no such
enhancers have been identiﬁed in the IC1–IC2 interval, although an
Ascl2 transgene rescuing the lethality of Ascl2 deﬁciency and
encompassing ~60 kb of our deletion has recently been described
(Rentsendorj et al., 2010).
The role of the spongiotrophoblast in the mouse placenta is unclear
but it is essential for development, since a complete lack of
spongiotrophoblast leads to midgestational lethality (Guillemot et al.,
1994; Oh et al., 2008). Previous work on Ascl2 has established that it
plays an important role in the formation of the spongiotrophoblast,
together with a negative role on trophoblast giant cell differentiation
from diploid ectoplacental precursors (Guillemot et al., 1995). Maternal
inheritance of theAscl2 null allele results inmidgestational lethality due
to a complete lack of spongiotrophoblast formation (Guillemot et al.,
1994). TheDel7AI allele gave us the opportunity to assess the phenotypic
consequences in the mature placenta associated with suboptimal Ascl2
levels. We show that the dosage of Ascl2 levels is critical for normal
placentation and that reduced Ascl2 results in a decreased spongio-
trophoblast population, lack of trophoblast glycogen cells, an expanded
giant cell layer, a reduction in placental size, and embryonic growth
restriction. Nevertheless, these suboptimal Ascl2 levels can still result in
viable pups, although growth retarded.One of the drastic phenotypes described here is the disorganiza-
tion of the fetal vasculature. Observed from the maternal side, the
vascular bed is seen as a punctate structure with regularly spaced
openings organizing the underlying network of fetal capillaries. In the
mutants with a stunted spongiotrophoblast layer, this organization is
lost and the labyrinth ﬁlls the entire placenta. Our results therefore
suggest that ﬁnger-like projections of the spongiotrophoblast within
the labyrinth play an important role, structurally and perhaps also
functionally via themaintenance of an organized vascular network for
proper feto-maternal exchanges. Although this aspect of the pheno-
type has not been studied in detail here, it is likely that the observed
changes in fetal capillary beds and labyrinth trophoblast densities
would affect the expansion of the maternal blood spaces.
The phenotype studied here describes a functional placenta with
an apparent total loss of trophoblast glycogen cells. Both the
developmental origin and function of this cell lineage is currently
unknown (Coan et al., 2006). Based on the observation that these
glycogen-rich vacuolated cells are ﬁrst detected past midgestation
within the spongiotrophoblast layer and that they express markers of
spongiotrophoblast (such as Igf2 (Redline et al., 1993) and Tpbpa
(Lescisin et al., 1988)) it has been proposed that they may represent a
speciﬁc subtype of spongiotrophoblast cells. However it has been
shown that Pcdh12, which is speciﬁcally expressed in trophoblast
glycogen cells past mid-gestation (Rampon et al., 2005), also labels a
speciﬁc sub-population of cells within the ectoplacental cone at E7.5
(Bouillot et al., 2006). This led the authors to suggest that trophoblast
glycogen cells and spongiotrophoblast might represent distinct
trophoblast lineages both emerging from Ascl2-positive ectoplacental
cone (EPC) precursors. Our results clearly show that Ascl2 is required
for formation of the trophoblast glycogen cell lineage. Whether this is
mediated via a direct requirement for Ascl2 in precursors of the
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themselves dependent on Ascl2 will have to be addressed by lineage-
speciﬁc knock out experiments.
With regards to the function of trophoblast glycogen cells during
development, our results suggest that this trophoblast lineage is not
required for parturition, as previously suggested (Coan et al., 2006), at
least not within the context of mixed litters composed of wild type
and mutant conceptuses, as studied here. It might be informative to
analyze litters composed entirely of mutant conceptuses, an exper-
iment which would require embryo transfers since the homozygous
Del7AI/Del7AI are not viable (Lefebvre et al., 2009). However, it is
tempting to suggest that the absence of trophoblast glycogen cells
documented in Del7AI/+ heterozygotes might contribute to the
embryonic growth retardation phenotype observed. Although our
results are suggestive of a correlation between the absence of
trophoblast glycogen cells and embryonic growth restriction, we
cannot exclude the contributions of the abnormalities described in
other placental trophoblast cell types to the embryonic phenotype.
Therefore a deﬁnitive demonstration of the role of the trophoblast
glycogen cells on embryonic growth is still lacking and would require
the ablation of this speciﬁc lineage during development.
An intriguing aspect of our work is the ﬁnding that in addition to
Ascl2, a second IC2-regulated gene, the imprinted gene Phlda2, is also
affected in deletion heterozygotes. However the transcriptional
effects at both genes is opposite such that Phlda2 is upregulated in
the mutants. We considered the possibility that the deletion might
have a direct effect on Phlda2, for instance via the removal of a
silencer, but several of our results are not consistent with such a
model. The ﬁrst argument against this model is the structure of the
allele itself. The deletion has a distal breakpoint less than ﬁve kilobase
pairs away from Ascl2, whereas Phlda2 is located more than half a
megabase away from this breakpoint. Furthermore, both Tssc4 and
Cdkn1c, located in between Ascl2 and Phlda2 are not affected by Del7AI.
Second, the deletion has no effect on the embryonic expression of
Phlda2 and up-regulation is only observed in the placentae of Del7AI/+
mutants. Third, we showed that the levels of Phlda2 are also elevated
in Ascl2-null placentae, suggesting that Ascl2 acts upstream of Phlda2
and exerts negative effects on Phlda2-expressing cells, the syncytio-
trophoblast layer I. Finally, our analysis of markers for the other two
trophoblast cell types of the labyrinth layer at E15.5 also suggests an
increased cellularity in these lineages in the mature placenta. This
would suggest that a decreased dosage in Ascl2 and the ensuing
underdevelopment of the spongiotrophoblast have broader impacts
on chorionic ectoderm-derived lineages. Our results are consistent
with a model proposing that, as for the trophoblast giant cell lineage,
Ascl2 plays an inhibitory role on the differentiation of the trilaminar
trophoblast cell lineages of the labyrinth and that normal develop-
ment of the placenta requires an appropriate balance of positive and
negative signals governing the ratio of spongiotrophoblast and
labyrinth trophoblast precursors. Such a model could also help to
explain previously published intriguing results on the effects of
varying Phlda2 gene dosage. Phlda2 knockout mice are viable but their
placentae are characterized by placentomegaly, an expanded spon-
giotrophoblast layer and increased number of trophoblast glycogen
cells, but no fetal overgrowth (Frank et al., 2002). Although this has
not been addressed by the authors, we propose that increased
cellularity in the spongiotrophoblast layer of Phlda2-null placentae
might be mediated via an increase in Ascl2 levels. Conversely,
overexpression of Phlda2 from a BAC transgene leads to a reduced
spongiotrophoblast layer and defects in trophoblast glycogen cells,
changes which are accompanied by a reduction in Ascl2 levels
(Tunster et al., 2010). Together, these studies and our results suggest
a previously unrecognized relationship between Ascl2 and Phlda2.
Both are expressed in the ectoplacental cone (EPC) and extra-
embryonic ectoderm in early development, two layers which are
brought in close proximity with the collapse of the ectoplacentalcavity at E8.0 (Dunwoodie and Beddington, 2002; Guillemot et al.,
1994). We have conﬁrmed that ASCL2 and PHLDA2 are co-expressed
in the EPC at E7.5 (Fig. S2), arguing against a direct repression of
Phlda2 by ASCL2 at those early stages. Our results and those of others
(Frank et al., 2002; Salas et al., 2004; Tunster et al., 2010) could be
reconciled by proposing that each of these two genes play positive
roles in the maintenance of different precursor populations within
these layers, and that reduced levels in one are accompanied by
increased levels in the other, the proper balance assuring develop-
ment of a fully functional placenta.
It has been proposed that elevated levels of PHLDA2 are associated
with low birthweights (Apostolidou et al., 2007;Mcminn et al., 2006).
Although the ASCL2 gene might not be imprinted in human placenta
(Miyamoto et al., 2002), our results show that ASCL2 function is
dosage sensitive and suggest that ASCL2 mutations could be involved
in the etiology of these cases of intrauterine growth restriction (IUGR)
associated with upregulation of PHLDA2. The Del7AI mouse line will
provide a valuable model for the study of IUGR in the mouse,
including its consequences on maternal physiology during pregnancy
and postnatal adult phenotypes in growth retarded pups.Author contributions
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